Skip to content

Clinical trials

Phase 1/2 Myelodysplastic Syndromes trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20142
20162
20171
20182
20212
20222
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ciusss de L'Est de l'Île de Montréal2
Astex Pharmaceuticals, Inc.1
AstraZeneca1
Constellation Pharmaceuticals1
Forma Therapeutics, Inc.1
GlaxoSmithKline1
Karyopharm Therapeutics Inc1
NCIC Clinical Trials Group1
Novartis Pharmaceuticals1
PedAL BCU, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes15
Leukemia, Myeloid, Acute11
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia3
Leukemia, Myelomonocytic, Chronic3
Multiple Myeloma3
Hematologic Neoplasms2
Neoplasms2
Bone Marrow Diseases1
Colorectal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.